HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michael Stahl Selected Research
Michael Stahl Research Topics
Disease
23
Neoplasms (Cancer)
03/2024 - 01/2005
16
Adenocarcinoma
01/2024 - 07/2006
8
Stomach Neoplasms (Stomach Cancer)
10/2023 - 10/2005
5
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2024 - 03/2003
5
Carcinoma (Carcinomatosis)
01/2024 - 04/2009
4
Esophageal Neoplasms (Esophageal Cancer)
01/2024 - 01/2005
2
Neoplasm Metastasis (Metastasis)
01/2024 - 04/2009
2
Squamous Cell Neoplasms (Squamous Cell Cancer)
05/2015 - 11/2012
1
Residual Neoplasm
01/2024
1
Mucositis
11/2020
1
Hemorrhage
02/2020
1
Vision Disorders (Hemeralopia)
01/2020
1
Peritoneal Neoplasms
01/2018
1
Infections
01/2018
1
Nausea
01/2018
1
Abdominal Pain (Pain, Abdominal)
01/2018
1
Pancreatic Neoplasms (Pancreatic Cancer)
10/2016
1
Disease Progression
10/2016
1
Hand-Foot Syndrome
08/2015
1
Breast Neoplasms (Breast Cancer)
08/2015
1
Genomic Instability
09/2013
1
Esophageal Squamous Cell Carcinoma
01/2012
1
Legionnaires' Disease (Legionnaire's Disease)
02/2010
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2007
1
Colorectal Neoplasms (Colorectal Cancer)
01/2005
1
Weight Loss (Weight Reduction)
01/2005
1
Neuroblastoma
01/2004
Drug/Important Bio-Agent (IBA)
6
Paclitaxel (Taxol)
FDA Link
Generic
03/2024 - 11/2020
4
Platinum
IBA
03/2024 - 01/2020
4
Ramucirumab
IBA
01/2024 - 01/2020
3
Fluorouracil (Carac)
FDA Link
Generic
06/2023 - 10/2005
2
Nivolumab
IBA
01/2024 - 10/2023
2
Leucovorin (Folinic Acid)
FDA Link
06/2023 - 10/2005
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
12/2022 - 04/2009
2
Docetaxel (Taxotere)
FDA Link
01/2022 - 02/2020
2
Carboplatin (JM8)
FDA Link
Generic
01/2021 - 04/2007
2
Cetuximab (Erbitux)
FDA Link
01/2021 - 02/2020
2
Cisplatin (Platino)
FDA Link
Generic
02/2020 - 10/2005
2
Biomarkers (Surrogate Marker)
IBA
01/2018 - 11/2012
2
Capecitabine (Xeloda)
FDA Link
08/2015 - 04/2009
1
avelumab
IBA
01/2024
1
Immune Checkpoint Inhibitors
IBA
01/2024
1
Ipilimumab
IBA
10/2023
1
Irinotecan (Camptosar)
FDA Link
Generic
06/2023
1
Everolimus
FDA Link
11/2020
1
vinyltriethoxysilane (VTES)
IBA
02/2020
1
Trastuzumab (Herceptin)
FDA Link
01/2020
1
Taxoids (Taxanes)
IBA
01/2020
1
Enzymes
IBA
01/2018
1
Epidermal Growth Factor (EGF)
IBA
01/2018
1
catumaxomab
IBA
01/2018
1
Gemcitabine
FDA Link
10/2016
1
130-nm albumin-bound paclitaxel
IBA
10/2016
1
Urea (Carbamide)
FDA Link
Generic
08/2015
1
DNA (Deoxyribonucleic Acid)
IBA
09/2013
1
Mechanistic Target of Rapamycin Complex 2
IBA
09/2013
1
Glucosyltransferases
IBA
02/2010
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
04/2009
1
Bendamustine Hydrochloride
FDA Link
04/2007
1
Alkylating Agents
IBA
04/2007
1
Serine (L-Serine)
FDA Link
07/2006
1
Calcitonin (Calcitonin, Eel)
FDA Link
Generic
01/2004
1
Peptides (Polypeptides)
IBA
01/2004
Therapy/Procedure
18
Drug Therapy (Chemotherapy)
01/2024 - 10/2005
15
Therapeutics
01/2024 - 01/2005
13
Chemoradiotherapy
01/2024 - 03/2003
6
Radiotherapy
02/2020 - 07/2006
4
Combined Modality Therapy
07/2015 - 01/2005
4
Induction Chemotherapy
05/2015 - 01/2005
3
Neoadjuvant Therapy
10/2023 - 02/2020
2
Immunotherapy
01/2024 - 10/2023
1
Palliative Care (Palliative Therapy)
01/2024
1
Lasers (Laser)
01/2020
1
Wearable Electronic Devices
01/2020
1
Combination Drug Therapy (Combination Chemotherapy)
02/2009
1
Adjuvant Chemoradiotherapy
02/2009
1
Adjuvant Chemotherapy
01/2005